Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Interindividual variability in the hepatic expression of the human breast cancer resistance protein (BCRP/ABCG2): effect of age, sex, and genotype.

Prasad B, Lai Y, Lin Y, Unadkat JD.

J Pharm Sci. 2013 Mar;102(3):787-93. doi: 10.1002/jps.23436. Epub 2013 Jan 1.

PMID:
23280364
[PubMed - indexed for MEDLINE]
2.

LC-MS/MS mediated absolute quantification and comparison of bile salt export pump and breast cancer resistance protein in livers and hepatocytes across species.

Li N, Palandra J, Nemirovskiy OV, Lai Y.

Anal Chem. 2009 Mar 15;81(6):2251-9. doi: 10.1021/ac8024009.

PMID:
19209887
[PubMed - indexed for MEDLINE]
3.

Breast cancer resistance protein (ABCG2) and drug disposition: intestinal expression, polymorphisms and sulfasalazine as an in vivo probe.

Urquhart BL, Ware JA, Tirona RG, Ho RH, Leake BF, Schwarz UI, Zaher H, Palandra J, Gregor JC, Dresser GK, Kim RB.

Pharmacogenet Genomics. 2008 May;18(5):439-48. doi: 10.1097/FPC.0b013e3282f974dc.

PMID:
18408567
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Interindividual variability in hepatic expression of the multidrug resistance-associated protein 2 (MRP2/ABCC2): quantification by liquid chromatography/tandem mass spectrometry.

Deo AK, Prasad B, Balogh L, Lai Y, Unadkat JD.

Drug Metab Dispos. 2012 May;40(5):852-5. doi: 10.1124/dmd.111.043810. Epub 2012 Feb 8.

PMID:
22318656
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Interindividual variability in hepatic organic anion-transporting polypeptides and P-glycoprotein (ABCB1) protein expression: quantification by liquid chromatography tandem mass spectroscopy and influence of genotype, age, and sex.

Prasad B, Evers R, Gupta A, Hop CE, Salphati L, Shukla S, Ambudkar SV, Unadkat JD.

Drug Metab Dispos. 2014 Jan;42(1):78-88. doi: 10.1124/dmd.113.053819. Epub 2013 Oct 11.

PMID:
24122874
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine.

Zamber CP, Lamba JK, Yasuda K, Farnum J, Thummel K, Schuetz JD, Schuetz EG.

Pharmacogenetics. 2003 Jan;13(1):19-28.

PMID:
12544509
[PubMed - indexed for MEDLINE]
7.

Association of breast cancer resistance protein/ABCG2 phenotypes and novel promoter and intron 1 single nucleotide polymorphisms.

Poonkuzhali B, Lamba J, Strom S, Sparreboom A, Thummel K, Watkins P, Schuetz E.

Drug Metab Dispos. 2008 Apr;36(4):780-95. doi: 10.1124/dmd.107.018366. Epub 2008 Jan 7.

PMID:
18180275
[PubMed - indexed for MEDLINE]
Free Article
8.

Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver.

Merino G, van Herwaarden AE, Wagenaar E, Jonker JW, Schinkel AH.

Mol Pharmacol. 2005 May;67(5):1765-71. Epub 2005 Feb 18.

PMID:
15722455
[PubMed - indexed for MEDLINE]
Free Article
9.

Functional SNPs of the breast cancer resistance protein-therapeutic effects and inhibitor development.

Yanase K, Tsukahara S, Mitsuhashi J, Sugimoto Y.

Cancer Lett. 2006 Mar 8;234(1):73-80. Epub 2005 Nov 21. Review.

PMID:
16303243
[PubMed - indexed for MEDLINE]
10.

Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).

Doyle L, Ross DD.

Oncogene. 2003 Oct 20;22(47):7340-58. Review.

PMID:
14576842
[PubMed - indexed for MEDLINE]
11.

Hepatic and renal Bcrp transporter expression in mice treated with perfluorooctanoic acid.

Eldasher LM, Wen X, Little MS, Bircsak KM, Yacovino LL, Aleksunes LM.

Toxicology. 2013 Apr 5;306:108-13. doi: 10.1016/j.tox.2013.02.009. Epub 2013 Feb 19.

PMID:
23435180
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Breast cancer resistance protein in pharmacokinetics and drug-drug interactions.

Xia CQ, Yang JJ, Gan LS.

Expert Opin Drug Metab Toxicol. 2005 Dec;1(4):595-611. Review.

PMID:
16863427
[PubMed - indexed for MEDLINE]
13.

MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).

Jiao X, Zhao L, Ma M, Bai X, He M, Yan Y, Wang Y, Chen Q, Zhao X, Zhou M, Cui Z, Zheng Z, Wang E, Wei M.

Breast Cancer Res Treat. 2013 Jun;139(3):717-30. doi: 10.1007/s10549-013-2607-x. Epub 2013 Jun 19.

PMID:
23780685
[PubMed - indexed for MEDLINE]
14.

C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance.

Imai Y, Nakane M, Kage K, Tsukahara S, Ishikawa E, Tsuruo T, Miki Y, Sugimoto Y.

Mol Cancer Ther. 2002 Jun;1(8):611-6.

PMID:
12479221
[PubMed - indexed for MEDLINE]
Free Article
15.

Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.

Ceckova M, Libra A, Pavek P, Nachtigal P, Brabec M, Fuchs R, Staud F.

Clin Exp Pharmacol Physiol. 2006 Jan-Feb;33(1-2):58-65.

PMID:
16445700
[PubMed - indexed for MEDLINE]
16.

Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.

Zhang Y, Wang H, Wei L, Li G, Yu J, Gao Y, Gao P, Zhang X, Wei F, Yin D, Zhou G.

Breast Cancer Res Treat. 2010 Oct;123(3):679-89. doi: 10.1007/s10549-009-0660-2. Epub 2009 Dec 6.

PMID:
19967559
[PubMed - indexed for MEDLINE]
17.

Decreased hepatic breast cancer resistance protein expression and function in multidrug resistance-associated protein 2-deficient (TR⁻) rats.

Yue W, Lee JK, Abe K, Sugiyama Y, Brouwer KL.

Drug Metab Dispos. 2011 Mar;39(3):441-7. doi: 10.1124/dmd.110.035188. Epub 2010 Nov 24.

PMID:
21106720
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Sex-dependent disposition of acetaminophen sulfate and glucuronide in the in situ perfused mouse liver.

Lee JK, Abe K, Bridges AS, Patel NJ, Raub TJ, Pollack GM, Brouwer KL.

Drug Metab Dispos. 2009 Sep;37(9):1916-21. doi: 10.1124/dmd.109.026815. Epub 2009 Jun 1.

PMID:
19487254
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The ABCG2 C421A polymorphism does not affect oral nitrofurantoin pharmacokinetics in healthy Chinese male subjects.

Adkison KK, Vaidya SS, Lee DY, Koo SH, Li L, Mehta AA, Gross AS, Polli JW, Lou Y, Lee EJ.

Br J Clin Pharmacol. 2008 Aug;66(2):233-9. doi: 10.1111/j.1365-2125.2008.03184.x. Epub 2008 Apr 22.

PMID:
18429968
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Breast cancer resistance protein: molecular target for anticancer drug resistance and pharmacokinetics/pharmacodynamics.

Sugimoto Y, Tsukahara S, Ishikawa E, Mitsuhashi J.

Cancer Sci. 2005 Aug;96(8):457-65. Review.

PMID:
16108826
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk